The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Surasak Phuphanich

Neuro-Oncology Program

Department of Neurosurgery and Neurology

Cedars-Sinai Medical Center

Los Angeles

USA

[email]@cshs.org

Name/email consistency: high

[Claim this account]

Affiliations

Neuro-Oncology Program, Department of Neurosurgery and Neurology, Cedars-Sinai Medical Center, Los Angeles, USA. 2013
The New Approaches to Brain Tumor Therapy Consortium, NABTT Central Office, 1550 Orleans Street, Suite 1M-16, USA. 2010
Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. 2008

References

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Phuphanich, S., Wheeler, C.J., Rudnick, J.D., Mazer, M., Wang, H., Nuño, M.A., Richardson, J.E., Fan, X., Ji, J., Chu, R.M., Bender, J.G., Hawkins, E.S., Patil, C.G., Black, K.L., Yu, J.S. Cancer Immunol. Immunother. (2013) [Pubmed]
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma. Phuphanich, S., Supko, J.G., Carson, K.A., Grossman, S.A., Burt Nabors, L., Mikkelsen, T., Lesser, G., Rosenfeld, S., Desideri, S., Olson, J.J. J. Neurooncol. (2010) [Pubmed]
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma. Phuphanich, S., Carson, K.A., Grossman, S.A., Lesser, G., Olson, J., Mikkelsen, T., Desideri, S., Fisher, J.D. Neuro-oncology (2008) [Pubmed]